Announcing the new vice dean for research: Landon King, M.D.

Dear Colleagues:

I am pleased to announce that Landon King, M.D., the David Marine Professor of Medicine and Biological Chemistry, and director of the Division of Pulmonary and Critical Care Medicine, has agreed to become the next vice dean for research at Johns Hopkins Medicine, effective Sept. 1.

We have an enormous and important research enterprise here at Hopkins, and I know Landon is the right person for the job. He succeeds Chi Van Dang, who, as you know, is leaving in late August to become director of the University of Pennsylvania Abramson Cancer Center.

The school of medicine has been the largest recipient of NIH biomedical funding for the past 17 years, receiving $438.8 million in 2010. As vice dean for research, Landon will lead all aspects of basic and translational research at the school of medicine and work closely with me and other leaders across the university to support and further develop core resources and research infrastructure, and facilitate collaborative research across all of Johns Hopkins Medicine. He will also oversee research administration and policy coordination and help identify and coordinate technology transfer opportunities for Johns Hopkins Medicine.

After earning his medical degree in 1989 at Vanderbilt University, Landon completed his residency at Hopkins on the Osler Medical Service, where he served as an assistant chief of service. As a postdoctoral fellow, he studied water channels in the lung with 2003 Nobel Laureate Peter Agre. In 1997, Landon joined the faculty as an assistant professor, was named director of the Division of Pulmonary and Critical Care Medicine in 2005, and became a full professor in 2010.

The American Society for Clinical Investigation recognized Landon's important work on regulation and function of aquaporin water channel proteins by electing him a fellow in 2006. His current research focuses on the role of water channels in lung function, as well as immunologic mechanisms of recovery from lung injury. He has published numerous research articles and book chapters, mentored many graduate students and postdoctoral fellows, and serves on two editorial boards and a number of boards and committees both within Hopkins and nationwide.

Landon's exceptional qualities as a scientist herald a bright future for Hopkins Medicine's research under his leadership. Please join me in welcoming and supporting him in his new role.

Sincerely,

Edward D. Miller, M.D.
Dean of the Medical Faculty
CEO, Johns Hopkins Medicine